Insight and hostility as predictors and correlates of nonadherence in the European first episode schizophrenia trial

Journal of Clinical Psychopharmacology

Volumn 33, Issue 2, 2013, Pages 258-261

  Czobor, Pál ^a   Volavka, Jan ^b   Derks, Eske M ^c   Bitter, István ^a   Libiger, Jan ^d   Kahn, René S ^c   Wolfgang Fleischhacker, W ^e  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d CHARLES UNIVERSITY   (Czech Republic)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; EUROPE; HOSTILITY; INTROSPECTION; LETTER; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HOSTILITY; HUMANS; MALE; MEDICATION ADHERENCE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TIME FACTORS; YOUNG ADULT;

EID: 84874932244     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182856886     Document Type: Letter

References (9)

1. Mohamed S, Rosenheck R, McEvoy J, et al. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophr Bull. 2009;35(2):336-346.
2. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-1223. (Pubitemid 41345943)
3. Lindenmayer JP, Liu-Seifert H, Kulkarni PM, et al. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. J Clin Psychiatry. 2009;70(7): 990-996.
4. Kemp R, Hayward P, Applewhaite G, et al. Compliance therapy in psychotic patients: randomised controlled trial. BMJ. 1996; 312(7027):345-349. (Pubitemid 26050038)
5. Kahn RS, Fleischhacker WW, Boter H, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 2008;371(9618):1085-1097. (Pubitemid 351418005)
6. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand. 2002;106(4):286-290.
7. Volavka J, Czobor P, Derks EM, et al. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). J Clin Psychiatry. 2011;72(7):955-961.
8. Sanz M, Constable G, Lopez-Ibor I, et al. A comparative study of insight scales and their relationship to psychopathological and clinical variables. Psychol Med. 1998;28(2):437-446. (Pubitemid 28197558)
9. Lysaker P, Bell M. Work rehabilitation and improvements in insight in schizophrenia. J Nerv Ment Dis. 1995;183(2):103-106.